Immunostaining for thyroid transcription factor 1, Napsin A, p40, and cytokeratin 5 aids in differential diagnosis of non-small cell lung carcinoma

被引:12
|
作者
Ikeda, Satoshi [1 ]
Naruse, Keishi [2 ]
Nagata, Chigusa [1 ]
Kuramochi, Masami [3 ]
Onuki, Takuya [3 ]
Inagaki, Masaharu [3 ]
Suzuki, Keiko [1 ]
机构
[1] Tsuchiura Kyodo Gen Hosp, Dept Pathol, Tsuchiura, Ibaraki 3000053, Japan
[2] Natl Hosp Org Natl Kochi Hosp, Dept Pathol, Kochi 7808077, Japan
[3] Tsuchiura Kyodo Gen Hosp, Dept Resp Surg, Tsuchiura, Ibaraki 3000053, Japan
关键词
immunocytochemistry; lung cytopathology; scoring; FACTOR-I; PULMONARY; P63; ADENOCARCINOMA; EXPRESSION; CANCER; BREAST; DELTA-NP63; SPECIMENS; CYTOLOGY;
D O I
10.3892/ol.2015.3045
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The present study aimed to examine the effectiveness of immunostaining of cytological specimens in discerning squamous from non-squamous cell carcinoma. Various combinations of six antibodies were examined in order to determine the optimal combination for use in differential diagnosis. Immunostaining was performed using tumor imprint smears obtained from 70 lung carcinoma cases. The results were scored based on positive area and intensity. For objective evaluation, scores for thyroid transcription factor 1 (TTF-1), napsin A, and CK CAM5.2 were expressed with positive values, while those for p40, cytokeratin (CK) 5/6 and CK5 were expressed with negative values. Histograms were produced to evaluate which combination was the most effective in differentiating squamous cell carcinoma from adenocarcinoma. The sensitivity for these molecules in adenocarcinoma was 88% for TTF-1, 85% for napsin A, and 100% for CAM5.2. In squamous cell carcinomas, sensitivity was determined to be 90% for p40, 86% for CK5, and 76% for CK5/6. The specificity for these molecules was calculated as 100%, 95%, 43%, 98%, 100% and 95%, respectively. Each combination was evaluated for scoring and the values were averaged. The most effective combination for mode and mean was TTF-1, napsin A, p40, and CK5, for which all adenocarcinomas had a score >1, and all squamous cell carcinomas scored <-2. Immunostaining scoring may therefore be useful for the differential diagnosis of these carcinomas when a limited number of tumor cells are present.
引用
收藏
页码:2099 / 2104
页数:6
相关论文
共 50 条
  • [21] Value of p40/Napsin A (NapA) Dual Immunohistochemistry (IHC) in Subtyping Poorly-Differentiated Non-Small Cell Lung Cancer (NSCLC)
    Chen, Athena
    Kem, Marina
    Huynh, Tiffany
    Mino-Kenudson, Mari
    Ly, Amy
    LABORATORY INVESTIGATION, 2018, 98 : 728 - 729
  • [22] Analysis of thyroid transcription factor-1 and cytokeratin 20 separates merkel cell carcinoma from small cell carcinoma of lung
    Hanly, AJ
    Elgart, GW
    Jorda, M
    Smith, J
    Nadji, M
    JOURNAL OF CUTANEOUS PATHOLOGY, 2000, 27 (03) : 118 - 120
  • [23] Value of p40/Napsin A (NapA) Dual Immunohistochemistry (IHC) in Subtyping Poorly-Differentiated Non-Small Cell Lung Cancer (NSCLC)
    Chen, Athena
    Kem, Marina
    Huynh, Tiffany
    Mino-Kenudson, Mari
    Ly, Amy
    MODERN PATHOLOGY, 2018, 31 : 728 - 729
  • [24] The Role of p40 Immunostain in the Cytological Differential Diagnosis of Squamous Cell Carcinoma and Adenocarcinoma of the Lung
    Chen, X.
    Bao, Y.
    Wong, R.
    Politi, K.
    Jiao, L.
    Gettinger, S.
    Homer, R.
    Chhieng, D.
    Cai, G.
    LABORATORY INVESTIGATION, 2013, 93 : 86A - 86A
  • [25] Expression landscapes in non-small cell lung cancer shaped by the thyroid transcription factor 1
    Luna, Herdee Gloriane C.
    Imasa, Marcelo Severino
    Juat, Necy
    Hernandez, Katherine V.
    Sayo, Treah May
    Cristal-Luna, Gloria
    Asur-Galang, Sheena Marie
    Bellengan, Mirasol
    Duga, Kent John
    Buenaobra, Bien Brian
    De los Santos, Marvin I.
    Medina, Daniel
    Samo, Jamirah
    Literal, Venus Minerva
    Bascos, Neil Andrew
    Sy-Naval, Sullian
    LUNG CANCER, 2023, 176 : 121 - 131
  • [26] The Role of p40 Immunostain in the Cytological Differential Diagnosis of Squamous Cell Carcinoma and Adenocarcinoma of the Lung
    Chen, X.
    Bao, Y.
    Wong, R.
    Politi, K.
    Jiao, L.
    Gettinger, S.
    Homer, R.
    Chhieng, D.
    Cai, G.
    MODERN PATHOLOGY, 2013, 26 : 86A - 86A
  • [27] Differential diagnosis of non-small cell lung carcinoma by circulating microRNA
    Singh, Anjana
    Kant, Ravi
    Saluja, Tajindra Singh
    Tripathi, Tanya
    Srivastava, Kamini
    Naithani, Manisha
    Gupta, Anurag
    Mirza, Anissa Atif
    Prakash, Ved
    Singh, Satyendra Kumar
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2020, 16 (01) : 127 - +
  • [28] Agreement of CK5/6, p40, and p63 immunoreactivity in non-small cell lung cancer
    Kriegsmann, Katharina
    Cremer, Martin
    Zgorzelski, Christiane
    Harms, Alexander
    Muley, Thomas
    Winter, Hauke
    Kazdal, Daniel
    Warth, Arne
    Kriegsmann, Mark
    PATHOLOGY, 2019, 51 (03) : 240 - 245
  • [29] Differential expression and biodistribution of cytokeratin 18 and desmoplakins in non-small cell lung carcinoma subtypes
    Young, GD
    Winokur, TS
    Cerfolio, RJ
    Van Tine, BA
    Chow, LT
    Okoh, V
    Garver, RI
    LUNG CANCER, 2002, 36 (02) : 133 - 141
  • [30] A Study of ΔNp63 (p40) Expression in Non-Small Cell Lung Carcinomas
    Nonaka, D.
    MODERN PATHOLOGY, 2012, 25 : 485A - 485A